Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Markošová, Alan
DOB: 17-MAR-1941 (Age: 85)
Gender: male
Address:
Na Hrebienku 53
980 45 Vladiča (Slovakia)
ID: 3171-766886-2 (ECI)
Report
Date: 15-FEB-2019
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Detská fakultná nemocnica s poliklinikou Banská Bystrica
Námestie Ludvíka Svobodu 4
974 01 Banská Bystrica (Slovakia)
Specimen
Collected: 15-FEB-2019

Chemistry

Test 15-FEB-2019 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.0 H 4.8 - 5.9 %

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient’s HbA1c is mildly elevated, indicating suboptimal long-term glycemic control and possible prediabetes or diabetes. Further clinical correlation and monitoring of blood glucose levels are recommended to assess the need for intervention or adjustment of current management.